Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Roche restructures life science business

April 24, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Europe, Roche, US, cuts

Roche is to cut around 170 jobs in Europe and the US as part of a restructure of its life …
News
msi

The competitor room comes of age

April 24, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, competitor room

It was great to be back at SonoPharm, it was so still at this time of day and she went …
Feature

Specialist publisher acquires Pharmafile portfolio

April 24, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, Samedan, Wiley, pharmafile

Samedan Ltd has extended its range of market-leading pharmaceutical magazines with the acquisition of the Pharmafile portfolio. The London-based firm …
News
Merck image

HCV agreement for Merck and BMS

April 23, 2013 Research and Development, Sales and Marketing BMS, HCV, Merck

Merck & Co and Bristol-Myers Squibb have signed a non-exclusive agreement to conduct a Phase II trial looking at a …
News
astrazeneca image

AstraZeneca signs $200m nanomedicine deal

April 23, 2013 Research and Development, Sales and Marketing AstraZeneca, bind therapeutics, nanomedicine

AstraZeneca has signed an agreement to develop and commercialise a cancer nanomedicine from US firm Bind Therapeutics’ stable of Accurins. …
News
mike_narachi_orexigen

Orexigen’s chief executive elected to PhRMA Board

April 23, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PhRMA, orexigen

Biopharma firm Orexigen has announced that its president and chief executive Michael Narachi has been elected to the Board of …
Appointment
abpi_reception

‘No consensus’ on transparency

April 22, 2013 Medical Communications, Research and Development, Sales and Marketing ABPI, Goldacre, Whitehead, all trials, transparency

An ABPI meeting on increasing the transparency of the way clinical trials are reported has thrown up more questions than …
News
granger_nhs

New appointments to advise ministers on proposed NHS changes

April 22, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, granger, reforms

The Department of Health has announced that five new members will join the Independent Reconfiguration Panel (IRP) from May. The …
Appointment
stephen-williams

Venaxis appoints former Pfizer executive to Board of directors

April 19, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Pfizer, venaxis, williams

Diganostic firm Venaxis has appointed SomaLogic’s chief medical officer Stephen Williams to the company’s Board of directors.  
Appointment

Covance opens expanded Singapore lab

April 18, 2013 Research and Development Covance

Covance has expanded its central laboratory facility in Singapore to meet growing demand for drug development services in the Asia-Pacific …
News
lilly_scientists

Lilly increases Alzheimer’s R&D

April 18, 2013 Research and Development, Sales and Marketing Alzheimer's, lilly

Eli Lilly and Company has bought a new diagnostic technology which may help point to a different way of treating …
News

Oxford Cancer Biomarkers signs discovery deal with AstraZeneca

April 18, 2013 Research and Development AstraZeneca, Oxford Cancer Biomarkers

AstraZeneca has signed a new alliance with a UK firm in the field of biomarker discovery.Oxford Cancer Biomarkers is developing …
News
yoosuk

Teva-Handok names chief executive

April 17, 2013 Manufacturing and Production, Research and Development, Sales and Marketing teva-handok

Teva-Handok has announced the appointment of Yoo Suk Hong as the first chief executive of the business venture between Teva …
Appointment
lilly_corporate_hq

Lilly Phase III diabetes boost

April 17, 2013 Research and Development, Sales and Marketing diabetes, dulaglutide, lilly

Eli Lilly and Co’s new type II diabetes candidate dulaglutide – which it intends to file this year – has …
News
Caan image

Dragon’s Den entrepreneur expands into healthcare

April 17, 2013 Medical Communications, Research and Development, Sales and Marketing Dragon's den, ab prime advantage, james caan

James Caan, one of the panel of entrepreneurs on TV’s Dragons’ Den, is to expand his business into the healthcare …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025